152 related articles for article (PubMed ID: 15767116)
1. Simulation of a mathematical model of the role of the TFPI in the extrinsic pathway of coagulation.
Xu C; Hu Xu X; Zeng Y; Wen Chen Y
Comput Biol Med; 2005 Jun; 35(5):435-45. PubMed ID: 15767116
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor pathway inhibitor: structure, biology and involvement in disease.
Lwaleed BA; Bass PS
J Pathol; 2006 Feb; 208(3):327-39. PubMed ID: 16261634
[TBL] [Abstract][Full Text] [Related]
3. [Tissue factor pathway inhibitor (TFPI) and its role in pathology].
Rucińska M; Gacko M; Skrzydlewski Z
Postepy Hig Med Dosw; 1997; 51(4):421-30. PubMed ID: 9446103
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor pathway inhibitor.
Camici M; Sagripanti A
Minerva Med; 1999; 90(1-2):25-32. PubMed ID: 10388460
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor and tissue factor pathway inhibitor.
Price GC; Thompson SA; Kam PC
Anaesthesia; 2004 May; 59(5):483-92. PubMed ID: 15096242
[TBL] [Abstract][Full Text] [Related]
6. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
[TBL] [Abstract][Full Text] [Related]
7. Protein S as cofactor for TFPI.
Hackeng TM; Rosing J
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2015-20. PubMed ID: 19661488
[TBL] [Abstract][Full Text] [Related]
8. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
[TBL] [Abstract][Full Text] [Related]
9. Models of blood coagulation.
Mann KG; Brummel-Ziedins K; Orfeo T; Butenas S
Blood Cells Mol Dis; 2006; 36(2):108-17. PubMed ID: 16500122
[TBL] [Abstract][Full Text] [Related]
10. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.
Hackeng TM; Seré KM; Tans G; Rosing J
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3106-11. PubMed ID: 16488980
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
[TBL] [Abstract][Full Text] [Related]
12. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.
Mackman N; Tilley RE; Key NS
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1687-93. PubMed ID: 17556654
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor and tissue factor pathway inhibitor: a potential role in pregnancy and obstetric vascular complications?
Dusse LM; Carvalho Md; Cooper AJ; Lwaleed BA
Clin Chim Acta; 2006 Oct; 372(1-2):43-6. PubMed ID: 16713593
[TBL] [Abstract][Full Text] [Related]
14. The role of tissue factor pathway inhibitor in tumor growth and metastasis.
Amirkhosravi A; Meyer T; Amaya M; Davila M; Mousa SA; Robson T; Francis JL
Semin Thromb Hemost; 2007 Oct; 33(7):643-52. PubMed ID: 18000790
[TBL] [Abstract][Full Text] [Related]
15. Blood coagulation dynamics: mathematical modeling and stability results.
Sequeira A; Santos RF; Bodnár T
Math Biosci Eng; 2011 Apr; 8(2):425-43. PubMed ID: 21631138
[TBL] [Abstract][Full Text] [Related]
16. Protein S is a cofactor for tissue factor pathway inhibitor.
Rosing J; Maurissen LF; Tchaikovski SN; Tans G; Hackeng TM
Thromb Res; 2008; 122 Suppl 1():S60-3. PubMed ID: 18691502
[TBL] [Abstract][Full Text] [Related]
17. Tolerance and threshold in the extrinsic coagulation system.
Müller J; Brandt S; Mayerhofer K; Tjardes T; Maegele M
Math Biosci; 2008 Feb; 211(2):226-54. PubMed ID: 17936855
[TBL] [Abstract][Full Text] [Related]
18. Mathematical modeling of blood coagulation cascade: kinetics of intrinsic and extrinsic pathways in normal and deficient conditions.
Zhu D
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):637-46. PubMed ID: 17890951
[TBL] [Abstract][Full Text] [Related]
19. Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation.
Parunov LA; Fadeeva OA; Balandina AN; Soshitova NP; Kopylov KG; Kumskova MA; Gilbert JC; Schaub RG; McGinness KE; Ataullakhanov FI; Panteleev MA
J Thromb Haemost; 2011 Sep; 9(9):1825-34. PubMed ID: 21696535
[TBL] [Abstract][Full Text] [Related]
20. Relative roles of tissue factor pathway inhibitor and antithrombin in the control of thrombogenesis.
Abildgaard U
Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S45-9. PubMed ID: 7647220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
